Keywords: Platinum(II) Schiff base Photocytotoxicity Cellular imaging Singlet oxygen a b s t r a c t Nine photo-stable Pt(II) Schiff base complexes [Pt(O^N^N^O)] (Pt1-Pt9) containing tetradentate salicylaldimine chelating ligands have been synthesized and characterized as potential photosensitisers for photodynamic therapy (PDT). The effects of electron-withdrawing versus electron-donating substituents on their electronic spectral properties are investigated. Pt1-Pt9 show broad absorption bands between 400-600 nm, which makes them useful for green-light photodynamic therapy. The complexes showed intense phosphorescence with emission maxima at ca. 625 nm. This emission was used to track their cellular localization in cancer cells. Confocal cellular imaging showed that the complexes localized mostly in the cytoplasm. In the dark, the complexes were non-toxic to A549 human lung cancer cells, but exhibited high photo-toxicity upon low-dose green light (520 nm, 7.02 J/cm 2 ) irradiation via photo-induced singlet oxygen generation. Thus, these photoactive Pt(II) complexes have the potential to overcome the problem of drug resistance and side effects of current clinical Pt(II) drugs, and to act as both theranostic as well as therapeutic agents.
Introduction
Photodynamic therapy (PDT) is a non-invasive method used to treat several types of cancer as well as bacterial or fungal infections, and various skin diseases [1] . PDT requires the simultaneous presence of photosensitizers (PSs), oxygen and light [2] . Upon light activation, the PSs generate reactive oxygen species (ROS) such as singlet oxygen and hydroxyl radicals [3] . These ROS cause severe oxidative damage to biomacromolecules such as proteins and DNA in cancer cells, which triggers cell death [4] . The current clinically approved PSs such as Photofrin, Chlorin e6 and Foscan share a similar tetrapyrrolic scaffold [5] . As a result, these PSs have similar limitations in clinical use, including 1) photo-instability; 2) high tissue retention times; 3) severe skin sensitivity, and 4) side effects such as hepatitis [6, 7] . Due to the 'heavy-atom effect', the introduction of a heavy metal can significantly enhance the efficiency of PDT. In recent years, metal-based tetrapyrrolic derivatives have been introduced into clinical trials as PDT agents [8, 9] . For example, the Pd(II) complex, WST11 shows high absorbance at 763 nm with the 2-3Â deeper light penetration depth than Photofrin [10] . However, due to the tetrapyrrolic scaffold, WST11 undergoes rapid photo-degradation which can limit its applications [11] .
To overcome the above limitations, polypyridyl metal complexes have recently attracted significant attention as candidates for use in PDT with high photo-stability and enhanced aqueous solubility [12] [13] [14] [15] [16] . Among these complexes, TLD-1433, a Ru(II) PS has entered clinical trials for non-muscle-invasive bladder cancer [17] .
On the other hand, Pt(II) complexes such as cisplatin, carboplatin, and oxaliplatin are the most widely administered anticancer drugs in clinic, but their use can be accompanied by side effects and drug resistance [18] . To overcome these restrictions, over the last decade, Pt(IV) prodrugs which undergo reduction or lightinduced activation have achieved promising therapeutic effects [19, 20] . The aim of the present work was to investigate novel Pt (II)-based PSs for PDT which might have fewer side effects and a different mechanism of action to circumvent resistance to Pt(II) chemotherapeutics, as well as the disadvantages of the current organic PDT agents. Recently, Pt(II) complexes have been reported as PDT agents [21] [22] [23] [24] , although Pt(II) Schiff base complexes have been rarely studied, despite their high triplet-triplet annihilation (TTA) efficiency as a result of the efficient intersystem crossing (ISC), strong visible light absorption, and high chemical and photo stability [25] [26] [27] [28] . Herein, we report the synthesis, photocytotoxicity, and cellular imaging properties of nine new Pt(II) Schiff base complexes (Pt1-Pt9). Two of the complexes have been characterized by X-ray crystal structure determinations. The electronic absorption and emission properties of the complexes are discussed. The complexes have a broad visible band at ca. 400-600 nm, suitable for visible light PDT and show strong phosphorescence at ca. 625 nm with enhancement of phosphorescence in viscous and hydrophobic solvents for near-IR cellular imaging. The complexes mostly localize in the cytoplasm of cancer cells and exhibit significant photocytotoxicity, while remaining non-toxic in the dark. Overall, these complexes have potential for use in photodynamic anticancer therapy.
Experimental

Materials
All solvents were of analytical grade. All buffer components were of biological grade and used as received. Benzene-1,2-diamine, salicylaldehyde, and 5-methylsalicyclaldehyde, were obtained from Acros, 4,5-dimethyl-1,2-phenyleneamine, 5-fluorosalicyclaldehyde, 1,2-diamino-4,5-difluorobenzene, sulforhodamine B (SRB), Hoechst 33342, sodium acetate and K 2 PtCl 4 , from SigmaAldrich, and MitoTracker deep red FM (MTR) and LysoTracker green (LTG) from Life Technologies (USA).
Instruments and methods
X-ray crystallography
Single crystals of Pt5 and Pt9 were grown by slow vapour diffusion of diethyl ether into N,N-dimethylformamide solutions of Pt5 or Pt9. A suitable crystal was selected and mounted on a glass fibre with Fromblin oil and placed on an Xcalibur Gemini diffractometer with a Ruby CCD area detector. The crystal was kept at 150(2) K during data collection. Using Olex2 [29] , the structure was solved with the ShelXT [30] structure solution program using Intrinsic Phasing and refined with the ShelXL [31] refinement package using Least Squares minimisation. X-ray crystallographic data for Pt5 and Pt9 have been deposited in the CCDC under the accession numbers 1888366 and 1888367, respectively.
Electrochemistry
Cyclic voltammetry (CV) experiments were carried out using a CH Instrument model 600D Electrochemical Analyzer/Workstation (Austin, TX). The electrochemical measurements were performed on Pt1-Pt9 (1.0 mM) in acetonitrile solutions containing tetrabutylammonium hexafluorophosphate (0.1 M) as supporting electrolyte. The solutions were degassed under nitrogen and cyclic voltammograms were scanned from À2.3 V to +2.3 V (three complete scans for each experiment). In a typical electrochemical experimental set up, the three-electrode system was used: a glassy carbon electrode as the working electrode, Ag/AgCl in 3.0 M KCl as the reference electrode, and platinum wire as the counter electrode. CV was performed at a scan rate of 100 mV/s. The excited state redox potentials were calculated from the ground state redox potentials and the emission maxima to aid evaluation of the photosensitization properties of Pt1-Pt9. Electronic absorption spectra were recorded on a Cary 300 UVVis spectrophotometer using 1-cm pathlength quartz cuvettes (3 mL) and a PTP1 Peltier temperature controller. Spectra were processed using UV Winlab software. Experiments were carried out at 293 K from 600 to 200 nm.
Phosphorescence emission measurements were obtained on a JASCO FP-6500 spectrofluorometer. Complexes (10 lM) in acetonitrile were diluted from a stock solution in DMSO (1 mM). The complexes were excited at k ex = 405 nm, 465 nm and 520 nm in a 1-cm quartz cuvette at 298 K. Experiments were performed under air or nitrogen.
Electrospray ionization mass spectra were obtained by preparing the samples in 50% methanol/50% H 2 O (v/v), or using NMR samples, for infusion into the mass spectrometer (Bruker Esquire 2000). The mass spectra were recorded with a scan range of m/z 400-1000 or 800-2000 for positive ions.
CHN analyses were carried out on a CE-440 elemental analyzer by Warwick Analytical (UK) Ltd.
Determination of singlet oxygen quantum yield
The singlet oxygen production quantum yield was determined by the N,N-dimethyl-4-nitrosoaniline/imidazole assay based on the oxidation of imidazole by singlet oxygen by following the reaction of oxidized imidazole with N,N-dimethyl-4-nitrosoaniline, as reported [33] . The absorbance of the complex was adjusted to ca. 0.1 at the irradiation wavelength. Complexes Pt1-Pt9 (1 mM) in DMSO were diluted in 4 mL acetonitrile solution containing N,Ndimethyl-4-nitrosoaniline (20 lM) and imidazole (2 mM), and irradiated in 1-cm pathlength quartz fluorescence cuvettes. Bleaching of N,N-dimethyl-4-nitrosoaniline was followed by monitoring of absorbance at 520 nm. Negative control experiments were run by repetition of the measurements in the absence of imidazole. The absorbance at 420 nm was plotted as a function of irradiation time and the quantum yields of singlet oxygen formation (U sample) were calculated using Rose Bengal as the standard (U reference ) and the following formula:
S represents the slope of the absorbance vs. irradiation time, I the rate of absorption calculated as the overlap of lamp emission spectra and the absorption spectra of the compound according to the following formula:
where I 0 represents the light-flux intensity of the lamp and A is the absorbance of the compound.
Phosphorescence quantum yields and lifetimes
Phosphorescence quantum yields were measured on a Fluorolog spectrofluorometer (Horiba Jobin Yvon) equipped with a 405 nm pulsed diode NanoLED light source. Pt(II) complexes were diluted from a stock solution in DMSO (1 mM) to achieve an absorbance = 0.1 at 405 nm in acetonitrile. The complexes were excited at k ex = 405 nm in a 1-cm quartz cuvette at 298 K. Experiments were performed in air, and emission spectra were corrected for the spectral sensitivity of the detection system by standard correction curves. Quantum yields in aerated acetonitrile were determined by comparison with the emission of [Ru(bpy) 3 ]Cl 2 in aerated water (U = 0.040). Phosphorescence lifetime measurements using the same equipment and measurement procedure were continued until 1000 counts of excited state species had been gathered. The raw data were analyzed with OriginPro 2016 software by using exponential functions to obtain the phosphorescence lifetimes. ). Then the cells were allowed to recover for a further 44 h in the incubator at 310 K. For dark-treated cells, after drug exposure, the cells were incubated in drug-free cell culture medium at 310 K for 44 h. Finally, the cytotoxicity was determined by sulforhodamine B (SRB) assay on a GloMax-Multi Microplate Multimode Reader. IC 50 values were determined as duplicates of triplicates in two independent sets of experiments and their standard deviations were calculated.
Synthesis of the
2.2.7.3. Cellular localization assays. A549 cells were seeded in a glass-bottom dish (35 mm dish with 20 mm bottom well (Costar) at 310 K in a 5% CO 2 /95% air incubator. The cells were incubated with Pt1-Pt9 (5 lM) at 310 K for 4 h and further stained with 100 lM MTR and LTR or Hoechst 33,342 Cell imaging was carried out immediately by confocal microscopy (LSM 710, Carl Zeiss, Göttingen, Germany) with a 63 Â oil-immersion objective lens. Excitation/emission: 1 one-photon 405/562 nm and two-photon 760/562 nm, LTG 488/520 nm, MTR 633/660 nm.
Results and discussion
Synthesis and characterization
To investigate the relationship between the photophysical, photochemical and photobiological activity of the Pt(II) Schiff base complexes, we designed and synthesized complexes Pt1-Pt9 (Scheme 1) with either electron-withdrawing or electron-donating groups at R 1 
X-Ray crystallography
Crystals of Pt5 and Pt9 (Fig. 1 , Table S1 ) suitable for X-ray diffraction were obtained via diffusion of ethyl ether into DMF solutions of the complexes. The complexes crystallized in the monoclinic space groups P2 1 /n and P2 1 /c, respectively, with four molecules in the unit cell. They are discrete mononuclear species with a PtN 2 O 2 core formed by the tetradentate O^N^N^O-donor Schiff base in a distorted square-planar environment. Pt-O bond distances are similar in both the complexes (ca. 1.99 Å), slightly longer than the Pt-N bond distances (ca. 1.96 Å, Table S2 ). Both the Pt-O and Pt-N bond distance lies in the range of the previous literature reports [22, 23] .
Photochemical and photophysical properties
The convenient structural modifications and facile synthesis of ligands made it possible to study the structure-activity relation- E x = 520 nm.
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26 nm bathochromic shift compared with Pt1 and as a result, the spectrum tail of Pt9 extended up to 600 nm which is ideal for near-IR light PDT [35] . Interestingly, Pt4 and Pt5 showed significant hypochromic effects and their molar extinction coefficients are much smaller than those for the other Pt(II) complexes.
Oxygen and viscosity sensitivity
Phosphorescence spectra of Pt1-Pt9 were recorded in acetonitrile at ambient temperature. Since all the Pt(II) complexes exhibit strong absorption across the whole visible range, the wavelength dependence of phosphorescence was investigated. Three excitation wavelengths were selected: 405 nm, 465 nm and 520 nm. As shown in Fig. 3 , Pt1-Pt9 (10 lM) all exhibited red phosphorescence between 604 and 644 nm. The highest emission intensity was obtained with excitation at 520 nm.
Similar to the UV-Vis absorption spectra, substitution at the R 1 or R 2 position also influenced the emission spectra (Fig. 3) . Pt1, Pt4
and Pt7 displayed the most blue-shifted emission maximum at 604, 607 and 609 nm, respectively, compared with R 2 -substituted complexes. Substitution with either -CH 3 or -F group at R 2 significantly shifted the emission maximum to longer wavelength (e.g. Pt1 604 nm, Pt2 625 nm, Pt3 633 nm) while the -F substituent showed a more effective red-shift than -CH 3 . Taking the emission and the UV-Vis data into consideration, it is apparent that a substituent at the R 2 position has a stronger effect on the emission and absorbance properties of Pt(II) Schiff base complexes than the R 1 position.
The emission spectra were recorded under N 2 in acetonitrile to investigate the effect of oxygen on the emission. As shown in Fig. 3a and b, the emission intensity of all the Pt(II) complexes under a nitrogen environment increased significantly compared to the intensity measured under air. Pt2 was the most oxygen-sensitive complex with a 32Â phosphorescence enhancement under nitrogen (Fig. 3c) . Pt1 showed the smallest emission enhancement (8Â) among all the Pt(II) complexes while it exhibited strongest emission in air. The phosphorescence of the complexes can be used to track the complexes inside cells by cellular imaging. Moreover, upon introducing functional groups, the phosphorescence intensity of Pt7 showed a better linear relationship with increasing concentration than Pt1 (Fig. 3d) . Thus the functional groups may introduce steric hindrance which might obstruct p-p stacking between the planar Pt(II) complexes.
Effect of solvent polarity and viscosity
The influence of polarity and viscosity on the emission of the complexes Pt1-9 is important for the possible use of these complexes as cellular imaging or PDT agents since the intracellular microenvironment is complicated with areas of varied polarity and viscosity [36] . As shown in Fig. 4 b, solvent polarity has only a little effect on the emission intensities. However, the viscosity of the solvent has a strong influence. The phosphorescence intensity was much higher in viscous solvents like glycerol compared to the other low viscosity solvents as depicted in Fig. 4a,b . Furthermore, at different percentages of glycerol/water the phosphorescence intensity was enhanced significantly with increased percentage of glycerol. Complex Pt7, in particular displayed the highest intensity enhancement in the presence of glycerol compared with all other Pt(II) complexes. The phosphorescence lifetime of Pt7 in acetonitrile and glycerol indicated (Fig. 4a ) that Pt7 has a more than 40x longer excited-state lifetime time in glycerol (3277 ns) than in acetonitrile (80.7 ns). These results indicate that high viscosity and hydrophobic environments enhance the phosphorescence intensity of these Pt(II) Schiff base complexes.
Cyclic voltammetry
Cyclic voltammograms of Pt1-Pt9 were recorded in degassed DMF (1 mM) with 100 mM tetrabutylammonium hexafluorophosphate (TBAP) as supporting electrolyte. All potentials are refer- case, there is one irreversible anodic peak with E pa at 0.424-0.687 V and one irreversible cathodic peak with E pc at À1.733 to À2.019 V (Fig. S2) . The anodic and cathodic peaks are attributed to the oxidation and reduction of Schiff base ligands, respectively [25] . Introduction of the -CH 3 group reduced the oxidation potential, while -F increased both the oxidation and reduction potentials in all of the complexes. The excited-state redox potentials of the complexes were determined in order to assess the photosensitization properties of the complexes (Table 1) . Upon excitation by green light, these Pt(II) Schiff base complexes became more reductive rather than oxidative.
Singlet oxygen generation
The highly oxygen-sensitive emission of the Pt(II) complexes indicates that the complexes probably interact with 3 O 2 in their excited states and may generate singlet oxygen ( 1 O 2 ) upon photo-excitation. Thus the singlet oxygen quantum yields of Pt1-Pt9 were determined in acetonitrile using both indirect and direct methods. The indirect method tracks the photo bleaching of N,Ndimethyl-4-nitrosoaniline (RNO) induced by imidazole and singlet oxygen over time. The direct method records the laser power dependence of near infrared singlet oxygen phosphorescence spectra, with Rose Bengal as a reference photosensitizer.
Singlet oxygen phosphorescence spectra with emission maximum at 1270 nm were observed for all the Pt(II) complexes (Fig. 5a,b) . Pt3, Pt6 and Pt7 with -F substitution showed relatively higher singlet oxygen quantum yields of 46%, 43% and 42%, respectively. Previous studies also showed that the presence of a fluorine substituent increases the antitumor effects with enhanced singlet oxygen generation [37, 38] . These Pt(II) complexes exhibited excellent photostability and solubility in acetonitrile during photo-irradiation, making them suitable as PDT agents.
Cell imaging and cellular localization
Based on the unique phosphorescence property of the complexes, confocal microscopy imaging of Pt1-Pt9 treated living A549 lung cancer cells under 520 nm excitation was carried out to track the complexes inside cancer cells. As shown in Fig. 6 , under 520 nm excitation, Pt1-Pt3 showed much stronger intracellular phosphorescence than the other Pt(II) complexes, especially Pt7-Pt9 whose intracellular phosphorescence was too weak to detect. From the cell imaging data, it was evident that the Pt(II) complexes have similar intracellular localization, mostly in the cytoplasm. Subsequently, to confirm whether these Pt(II) complexes can target specific organelles in the cytoplasm, Pt1 was selected for co-staining with commercial organelle dyes due to its strongest intracellular phosphorescence intensity. A549 lung cancer cells were firstly incubated with Pt1 (5 lM, 4 h) and then with specific organelle dyes (30 min) in the dark, and finally imaged with a confocal microscope. As shown in Fig. 7 , the red signal of Pt1 overlayed with both the fluorescence signal of Mitotracker green (mitochondrionstaining dye) and of Lysotracker green (lysosome-imaging dye). No overlay of luminescence was observed with the nucleus-staining dye Hoechst 33342. All these data indicate that these Pt(II) complexes target cell mitochondria and lysosomes rather than the cell nucleus. Clinically approved Pt(II) drugs such as cisplatin and carboplatin are known to target the cell nucleus and cross-link nuclear DNA [39] . Resistance to these Pt drugs occurs due to the repair of such platinum-DNA cross links by a nucleotide excision repair mechanism [40] . Hence these mitochondrion-and lysosome-targeting complexes could provide a novel mechanism of anticancer activity to overcome Pt-drug resistance.
Photocytotoxicity
After confirming the intracellular internalization and specific distribution of complexes Pt1-9 in A549 cancer cells, we explored the anticancer activity of these complexes, particularly as PDT agents considering their excellent ability to generate 1 O 2 . The anticancer activity of these complexes was studied both in the dark and upon light irradiation. As shown in Table 2 , all the Pt(II) complexes were non-toxic in A549 cancer cells in the dark up to 20 mM concentration, the cell survival percentages were all >80% after 4 h drug exposure followed by 44 h recovery. However, upon irradiation with a low dose of 520 nm green light (7.02 J/cm 2 ), significant photo-toxicity was observed, with several giving nanomolar IC 50 values. Pt2-Pt5 exhibited much better phototoxicity than Pt1 (which contained no substituents).
Conclusions
A series of platinum(II) Schiff Base salicylaldimine complexes (Pt1-Pt9) was synthesized with hydrogen, fluorine and methyl substituents on various positions on the phenyl rings of the backbone. The effect of electron withdrawing and donating substituents on the absorption and emission properties was investigated. These Pt(II) complexes show intense visible light absorption between 400 and 600 nm due to metal-to-ligand-charge-transfer (MLCT). Interestingly, the complexes showed viscosity and polarity-dependent strong emission upon green light excitation. Pt1-Pt9 showed excellent photo-stability under continuous light irradiation and generated singlet oxygen with a quantum yield of ca. 50%.
In the dark, all the complexes were non-toxic to A549 lung cancer cells. However, strong photo-toxicity was observed after excitation with low-dose green light (520 nm, 7.02 J cm À2 ). Cell imaging indicated that the complexes mostly localized in the cytoplasm, 
